Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
about
Biological significance of agmatine, an endogenous ligand at imidazoline binding sitesThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsImidazolines and pancreatic hormone secretion.Phentolamine block of KATP channels is mediated by Kir6.2.Pharmacological properties of the central antihypertensive agent, moxonidine.Investigation of morin-induced insulin secretion in cultured pancreatic cells.Characterization of the imidazoline binding site involved in regulation of insulin secretion.Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.Dynamic properties of I2-receptors.Interactions of angiotensin II with central catecholamines.Imidazolines and the pancreatic B-cell. Actions and binding sites.Serotonin 5-HT3 and 5-HT4 receptor antagonists.Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM.Evidence that the novel imidazoline compound FT005 is an alpha(2)-adrenoceptor agonistThe effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.Novel I1-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells.Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor.Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.Preparation and in vitro pharmacology of 5-HT4 receptor ligands. Partial agonism and antagonism of metoclopramide analogous benzoic esters.Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand.
P2860
Q24673628-87331404-CFAF-432F-825E-5C1788607DCBQ30486707-5420538E-42A1-465B-9289-29FD71375BDBQ33693050-882646B3-61FF-45B7-B56B-211458AC58D4Q36612957-BFE5EBA9-3EDA-44AD-822D-3AFE43180322Q37925014-95717292-541B-481D-94C8-D1CCFA0B1336Q38697506-7F6EAFA5-5C88-425D-B828-20581DD0A36CQ40483944-994A3569-C274-4605-9C2E-5E1248847E5DQ40483957-2578934D-3DC2-4CAD-9514-B2542ACFDA78Q40483970-6CFB0967-258B-4331-A571-43D1CCD9C6DCQ40516297-F23C2D5B-1FE0-4A2C-B1ED-FCCC42140803Q40940376-20B737F0-A2D8-4270-889B-7CF938A4BD27Q41370406-04099384-7FAC-415D-AEC6-047CF1223469Q41863153-6846C066-2569-41C1-92E2-4EF6ADCAE588Q41963463-84DC6BED-B5B6-4AF6-B0EA-D1A3A6F52BE5Q42060217-525A0B72-7180-48FE-89B9-BFDAFE2808C4Q42071939-8E328BDB-1468-447B-BCF7-2060C5442D8FQ42552128-2A5DEA33-8604-4060-B970-8726ACC855FEQ43172594-65A1D813-5D47-4C04-804A-896F77161E37Q46643534-8E9F58AD-AD88-430D-8493-4F96E0C569A4Q48226871-538FA358-1501-44AD-A1E4-663634E17DCB
P2860
Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@en
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@nl
type
label
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@en
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@nl
prefLabel
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@en
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@nl
P2093
P2860
P1476
Antagonism of the stimulatory ...... by the imidazoline, RX801080.
@en
P2093
M R Stillings
N G Morgan
P2860
P304
P356
10.1111/J.1476-5381.1993.TB13915.X
P407
P577
1993-11-01T00:00:00Z